⌘K

Login Start Free

Home/Filings/4/A/0000897069-25-000290

4/A//SEC Filing

Ng George K 4/A

Accession 0000897069-25-000290

CIK 0001533743other

View on SEC.gov Company Profile

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 5:53 PM ET

Size

8.9 KB

Accession

0000897069-25-000290

Insider Transaction Report

Form 4/AAmended

Period: 2025-01-27

Processa Pharmaceuticals, Inc.PCSA

DirectorChief Executive Officer

Transactions

Award
Warrants
2025-01-29+87,200→ 87,200 total(indirect: George Ng IRRA FBO: George Ng)
Exercise: $0.65From: 2025-01-29Exp: 2030-01-29→ Common Stock (87,200 underlying)
Award
Warrants
2025-01-29+43,600→ 43,600 total(indirect: George Ng IRRA FBO: George Ng)
Exercise: $0.65From: 2025-01-29Exp: 2030-01-29→ Common Stock (43,600 underlying)

Holdings

Common Stock
(indirect: George Ng IRRA FBO: George Ng)
87,200
Common Stock
(indirect: By Trust)
20,000

Documents

1 file

4
form4.xml

Issuer

Processa Pharmaceuticals, Inc.

CIK 0001533743

Entity typeother

Related Parties

1

filerCIK 0001638744

Filing Metadata

Form type: 4/A
Filed: Feb 17, 7:00 PM ET
Accepted: Feb 18, 5:53 PM ET
Size: 8.9 KB

View on SEC.gov